+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana



Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana



Annals of Tropical Medicine and Parasitology 98(4): 359-370



The pathogenesis of the sub-optimal response of Onchocerca volvulus to ivermectin was investigated in a 30-month follow-up of 28 individuals who, in a previous study, had been found to show a sub-optimal (N = 15) or adequate response (N = 13) to multiple treatments with the drug. Verbal informed consent was obtained before each subject was given a general clinical and ocular examination. Skin snips were taken from both iliac crests and both calves. Seventeen nodule carriers were hospitalized for nodulectomy. Adult worms were harvested, embryogrammes were constructed and all developmental stages were counted; degenerate, stretched microfilariae were noted separately. All the subjects were in good general health and all except one had received at least one additional treatment with ivermectin since the earlier study. A large proportion of the adult female worms in 10 out of the 11 sub-optimal responders who were nodule carriers were in full embryonic production but most of the stretched microfilariae they carried were degenerate. This picture is similar to that found in adult worms exposed to the first dose of ivermectin. In one subject who had no viable worms in his nodules, the existence of occult but actively reproductive worms was inferred from the high level of microfilaridermia observed less than 12 months after treatment. These observations confirm the existence of populations of adult female O. volvulus that respond poorly to repeated doses of ivermectin. The use of suramin in the treatment of the sub-optimal responders is discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004366998

Download citation: RISBibTeXText

PMID: 15228717

DOI: 10.1179/000349804225003442


Related references

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology 98(3): 231-249, 2004

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. Plos Neglected Tropical Diseases 3(7): E497, 2009

Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis. Tropical Medicine and International Health 16(9): 1112-1119, 2011

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. Plos Neglected Tropical Diseases 6(9): E1825, 2012

African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan). Transactions of the Royal Society of Tropical Medicine and Hygiene 101(7): 674-679, 2007

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Annals of Tropical Medicine and Parasitology 80(4): 433-442, 1986

The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. Tropical Medicine and Parasitology 40(3): 361-366, 1989

Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 85(2): 267-271, 1991

The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up. Ophthalmology 103(7): 1001-1008, 1996

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa. InternationalJournalofQualitativeStudiesonHealthandWell-Being6(2):, 2011

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria Journal 2(8): (24 March 2003), 2003

A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions. Tropical Medicine and Parasitology 40(3): 375-382, 1989

Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community. Transactions of the Royal Society of Tropical Medicine and Hygiene 86(3): 281-283, 1992